Critical illness policies sold in Singapore stay on the medical definitions in force at the time of purchase, and the regulator has now confirmed nobody is coming to update them.
Responding to a parliamentary question in May 2026 on whether insurers could reject claims where a newer surgical procedure is absent from legacy policy wording, the Monetary Authority of Singapore (MAS) said updating existing critical illness policies without a corresponding premium adjustment would threaten product sustainability.
Existing policyholders remain on the definitions in force when they purchased their policy, and the Life Insurance Association Singapore's periodic reviews of critical illness definitions apply only to new business going forward.
In practice, a policy sold five or 10 years ago may pay out against a narrower, older set of conditions than a policy sold today, and the client holding it has no reason to know that unless someone tells them.
The commercial pressure around older books points the same way. A December 2025 analysis by Milliman found that most critical illness products across Asia carry guaranteed-level premiums, meaning insurers absorb losses on in-force business as claims experience deteriorates, while reinsurers have raised critical illness rates within treaty limits, leaving primary insurers with limited room to adjust pricing on existing policies.
Neither the regulatory position nor the commercial one results in an existing policyholder being contacted about a gap in their own cover.
New claims data from Singlife make the case concrete. Across roughly 8,700 Singlife customers who filed a critical illness claim over the past 20 years, treatment-and-recovery activity continued for an average of 27 months, and in some cases for as long as 237 months, nearly 20 years.
That runs well past the five-year window the Life Insurance Association Singapore uses to benchmark critical illness protection need, a shortfall Singlife's own study puts at approximately S$169,000 in average recovery-related costs.
Within Singlife's book alone, critical illness claims incidence rose from approximately four claims per 1,000 customers in 2020 to 17 per 1,000 in 2025.
Industry-wide, life insurers paid S$1.14 billion in critical illness, death and total permanent disability claims under individual life policies in the first half of 2026, up 11.1% from the first half of 2025, according to Life Insurance Association Singapore data.
Set against the five-year assumption still used to benchmark protection need, that trend line suggests the assumption is increasingly out of step with what claimants actually experience.
The product side has moved to match the claims data, which gives advisers something concrete to offer rather than a vague warning. Prudential Singapore launched PRUActive Life V in March 2026, built around what the insurer calls "health gap years" — the period when a critical illness diagnosis keeps someone out of work while they recover — covering 182 conditions with the option to multiply coverage.
Etiqa Insurance Singapore had already added a Continuous Care Benefit to its Essential Critical Secure plan in 2024, paying monthly cash on top of the standard lump sum.
Singlife launched its own Care Collab Recovery Support Benefit in March 2026, available from April 1, 2026, providing S$20,000 over two years for home nursing and rehabilitation to customers holding both a Health Plus plan and CareShield or ElderShield coverage.
None of these arrive automatically to an existing client. A policyholder on an older CI plan gets none of the newer definitions, none of the continuous-payout structure, and none of the recovery-period benefits unless an adviser initiates the review and walks them through whether to supplement or replace what they hold.
The same claims data give that conversation a second act. Two in three critical illness survivors in Singlife's own study relied on family members as caregivers during recovery, and more than half of long-term care claims tracked in Singlife's Long-Term Care White Paper were linked to a prior critical illness.
Yet only 19% of Singaporeans have begun planning for long-term care, according to a July 2026 study, and the enhanced monthly CareShield Life payout of S$689 covers approximately 23% of the average long-term care cost reported by caregivers.
A critical illness review conducted on the strength of this data doesn't end at the CI policy. It surfaces a long-term care gap that the client was unlikely to have raised on their own, and that the insurer has no mechanism to flag either.
